Related references
Note: Only part of the references are listed.Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial
K. Albain et al.
CANCER RESEARCH (2019)
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
Melissa A. Troester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
Melissa A. Troester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer
Andreana N. Holowatyj et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Molecular Characterization and Mortality From Breast Cancer in Men
Suleiman Alfred Massarweh et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Impacts of Neighborhood Characteristics on Treatment and Outcomes in Women with Ductal Carcinoma In Situ of the Breast
Shiyang Zhang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer
Charles E. Geyer et al.
NPJ BREAST CANCER (2018)
Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era
Eleftherios P. Mamounas et al.
NPJ BREAST CANCER (2018)
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
David J. Press et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer
Albert J. Farias et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
Eleftherios P. Mamounas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Clinical utility of gene-expression signatures in early stage breast cancer
Maryann Kwa et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
Eleftherios P. Mamounas et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status
Albert J. Farias et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Breast Cancer Stage Variation and Survival in Association With Insurance Status and Sociodemographic Factors in US Women 18 to 64 Years Old
Christine D. Hsu et al.
CANCER (2017)
The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis
Leslie Hinyard et al.
BREAST (2017)
Underutilization of gene expression profiling for early-stage breast cancer in California
Rosemary D. Cress et al.
CANCER CAUSES & CONTROL (2016)
21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile
Jagar Jasem et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Disparity in Breast Cancer Late Stage at Diagnosis in Missouri: Does Rural Versus Urban Residence Matter?
Faustine Williams et al.
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2016)
Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study
Valentina I. Petkov et al.
NPJ BREAST CANCER (2016)
Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
Lindsey Enewold et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing
Megan C. Roberts et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Erica T. Warner et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Disparities in breast cancer stage at diagnosis in urban and rural adult women: a systematic review and meta-analysis
Sallyanne Nguyen-Pham et al.
ANNALS OF EPIDEMIOLOGY (2014)
Neighborhood socioeconomic deprivation, tumor subtypes, and causes of death after non-metastatic invasive breast cancer diagnosis: a multilevel competing-risk analysis
Min Lian et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Race and Hormone Receptor-Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
Joseph A. Sparano et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
Katie M. O'Brien et al.
CLINICAL CANCER RESEARCH (2010)
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
Kathy S. Albain et al.
LANCET ONCOLOGY (2010)
Referral, Receipt, and Completion of Chemotherapy in Patients With Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer Recurrence
Diana S. M. Buist et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Treatment Quality and Outcomes of African American Versus White Breast Cancer Patients: Retrospective Analysis of Southwest Oncology Studies S8814/S8897
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Underlying Causes of the Black-White Racial Disparity in Breast Cancer Mortality: A Population-Based Analysis
Idan Menashe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Age-Related Crossover in Breast Cancer Incidence Rates Between Black and White Ethnic Groups
William F. Anderson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen
Soonmyung Paik
ONCOLOGIST (2007)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Missed opportunities: Racial disparities in adjuvant breast cancer treatment
NA Bickell et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Comorbidity and survival disparities among black and white patients with breast cancer
CM Tammemagi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer
C Osborne et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Socioeconomic disparities in health: Pathways and policies
NE Adler et al.
HEALTH AFFAIRS (2002)
Share Paper
